| 000 | 01546 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518082547.0 | ||
| 264 | 0 | _c20210810 | |
| 008 | 202108s 0 0 eng d | ||
| 022 | _a1365-2710 | ||
| 024 | 7 |
_a10.1111/jcpt.13115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Xiao-Xue | |
| 245 | 0 | 0 |
_aInterlaboratory analysis of teicoplanin plasma concentration assays among Chinese laboratories. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cOct 2020 |
||
| 300 |
_a983-990 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLaboratories _xstandards |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTeicoplanin _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aJin, Peng-Fei | |
| 700 | 1 | _aLi, Peng-Mei | |
| 700 | 1 | _aXu, Shuo | |
| 700 | 1 | _aKong, Xu-Dong | |
| 700 | 1 | _aQin, Wei | |
| 700 | 1 | _aChen, Wen-Qian | |
| 700 | 1 | _aQin, Wang-Jun | |
| 700 | 1 | _aZhang, Xiang-Lin | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 45 _gno. 5 _gp. 983-990 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.13115 _zAvailable from publisher's website |
| 999 |
_c30564704 _d30564704 |
||